Simon Spohn

Senior Managing Consultant Radiation Oncology | Clinician Scientist @Uniklinik_Fr. Passionate about #GU cancers + imaging. Views are my own. @ESTRO_RT @degro_ev

[Radiation Oncology University Freiburg @RadOnc_UKF]

Excited to be at #ESTRO2026 in Stockholm 🇸🇪 — 11 team members, 14 contributions from the Department of Radiation Oncology University Medical Center Freiburg.
Let’s go! 🎉
#RadiationOncology
@ESTRO_RT

[Simon Spohn @Simon_Spohn]

Excited to share our new paper on intrafractional fiducial-based image guidance for focal dose-escalated SBRT in PCa now in PHIRO. This approach easily boosts precision & efficacy for linac-based SBRT in prostate cancer!

Check full paper here: https://t.co/wZy6l6hCcx

@ESTRO_RT

[Radiation Oncology University Freiburg @RadOnc_UKF]

Check out our comment on the WOLVERINE meta analysis just published in @TheLancetOncol !

MDT in prostate cancer is here to stay!

@Simon_Spohn @AncaGrosu1

https://t.co/yhO318muo1

[Simon Spohn @Simon_Spohn]

So proud of residents @SLBuerkle & Philipp Waibel for presenting at #EMUC25 in Prague 🙌 Their fantastic work earned a Highly Rated Abstract ribbon👌🏻! Great to see them representing our centre from Freiburg & Radiation Oncology with enthusiasm and quality.

[Simon Spohn @Simon_Spohn]

#EMUC25 in #Prague once again is a Highlight for everyone involved in #GU oncology. Excellent organization, high-level interdisciplinary scientific exchange and very instructive case discussions 🙌
@Uroweb
@ESTRO_RT

[Simon Spohn @Simon_Spohn]

Join us for this years #EMUC25 falcon workshop 🙌

[Alison Tree 💙 @alison_tree]

Coming to #EMUC25 ? Don’t miss the chance to sign up for the FALCON prostate contouring course @estro with superstar faculty @PaulSargos @Simon_Spohn and Thomas Zilli https://t.co/MYcTEtitRK

[Simon Spohn @Simon_Spohn]

Honored to join “Rising Stars in Oncology” at the Federal Ministry in Berlin 🇩🇪 representing UKF & Radiation Oncology. Minister Bär highlighted the need to strengthen top-level cancer research in Germany. 💡 #Oncology #CancerResearch #Networking

[Simon Spohn @Simon_Spohn]

Great to be part of the annual German/Swiss/Austrian Oncology Congress #DGHO25 in Cologne 🇩🇪 — sharing insights on SBRT in oligometastatic #ProstateCancer.
Inspiring discussions showing how multidisciplinary collaboration continues to shape the future of cancer care! 💡💬

[Simon Spohn @Simon_Spohn]

Leopoldina Symposium: AI & tech in medicine in the Focus. 🇩🇪 Debating Germany’s role as a research hub, regulatory updates & fostering innovation. Cross-sector exchange between medicine, science, industry & policy to drive future-ready clinical research. @Leopoldina @AncaGrosu1

[Priyamvada Maitre @docpriyamvada]

1st POSITIVE RCT in the #ASTRO2025 Plenary today! #BART meets primary EP of LRFS in High risk MIBC!!!

[Alison Tree 💙 @alison_tree]

This is big news 👇 No benefit to prophylactic nodal irradiation in NRG/RTOG 0924

[European Association of Urology (EAU) @Uroweb]

📣 Last call for #EMUC25 abstracts! 👉Are you ready to showcase your #UrologicalCancer research to help enhance the quality of uro-oncological care?

📅Submit by 1 August, 2025

See topic list & submission details here 👇
https://t.co/WWO4Somuva

@myESMO @ESTRO_RT

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data

https://t.co/WWqOHsaC0P

This systematic review and meta-analysis by the DADSPORT Collaboration evaluated the impact of hormone therapy (HT) added to postoperative radiotherapy (RT) in nonmetastatic #ProstateCancer across five randomized controlled trials involving 4,411 participants. While HT did not significantly improve overall survival (OS) in the general population, it did show meaningful benefits in metastasis-free survival (MFS) and prostate cancer–specific survival (PCSS), each with a 4% absolute improvement at 8 years.

Notably, OS benefits may be limited to patients with higher pre-RT PSA levels or CAPRA-S scores.

These findings support the use of adjuvant HT to improve cancer outcomes, particularly in higher-risk patients.

@DrSpratticus
@AmarUKishan
@drjefstathiou
@PCaParker
@_APollack
@PaulSargos
@felixfengmd

@OncoAlert
@Silke_Gillessen @AOmlin
@nataliagandur @bavilima

[Constantinos Zamboglou @CZamboglou]

Great to see many enthusiastic colleagues at our Co-IMPACT meeting. Thanks to all for coming and bringing this huge project forward! #ESTRO2025

[Simon Spohn @Simon_Spohn]

Excited to be part of the #EAU25 in Madrid! It’s an honor to give a presentstion at the Hands-on Training Course on „PSMA PET in guiding local treatment and MDT“Looking forward to exchange knowledge with colleagues and improving interdisciplinary patient care.
@Uroweb @ESTRO_RT

[Piet Ost @piet_ost]

@ESTRO_RT Voting is open!!! Would be happy to get your support. See you all in Vienna.

[Pierre Blanchard, MD @PBlanchardMD]

Hot of the press @IJROBP: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial

Full text here: https://t.co/MuEI1uURxQ

[Piet Ost @piet_ost]

Excited to run for a position in the ESTRO board. Be sure to vote. @ZilliThomas @PaulSargos @VedangMurthy @alison_tree @achoud72 @stephane_supiot @Mat_Guc and all others

[Radiation Oncology University Freiburg @RadOnc_UKF]

Today, the @Uniklinik_Fr and @VarianMedSys proudly hosted the official groundbreaking for the new Technology Innovation Lab 🙌🙌
This unique collaboration between academia and industry will pave the way for transformative breakthroughs in #cancer care
#HealthcareInnovation #TIL

[Simon Spohn @Simon_Spohn]

Last day of #EMUC24 is packed with highlights. Excellent talks by leaders of the field @AttardLab @alison_tree @Ecastromarcos and Wolfgang Fendler!
Special lecture by Ajay Aggarwal on the role of politics in cancer care ☀️
@ESTRO_RT @Uroweb @myESMO